The Chemical Data

Feinstein Institutes Study Noninvasive Bioelectronics

Feinstein Institutes Study Noninvasive Bioelectronics for Post-Surgery Blood Sugar Control

Feinstein Institutes Study Focused Ultrasound to Regulate Blood Sugar After Surgery Researchers and clinicians at Northwell Health’s Feinstein Institutes for Medical Research are breaking new ground in the field of bioelectronic medicine, exploring the use of focused ultrasound (FUS) to…

Read MoreFeinstein Institutes Study Noninvasive Bioelectronics for Post-Surgery Blood Sugar Control
NYB.AI and Pnaseer Partner to Advance

NYB.AI and Pnaseer Partner to Advance AI-Driven Hair Regeneration Research

NYB.AI and Pnaseer Form Strategic Alliance to Advance AI-Powered Hair Regeneration Research NYB.AI, a pioneer in AI-driven drug discovery, and Pnaseer Inc., a leader in bio-nanoparticle drug delivery technologies, have announced a strategic partnership to accelerate the discovery and development…

Read MoreNYB.AI and Pnaseer Partner to Advance AI-Driven Hair Regeneration Research
Agenus’ BOTBAL Shows 42% 2-Year Survival

Agenus’ BOT/BAL Shows 42% 2-Year Survival in MSS CRC, Moves Toward FDA Registration

Agenus’ BOT/BAL Combo Delivers 42% Two-Year Survival in MSS Colorectal Cancer: Phase 3 Trial Aligned with FDA Agenus Inc., a pioneer in immuno-oncology, announced compelling new clinical results and regulatory progress for its combination therapy of botensilimab and balstilimab (BOT/BAL).…

Read MoreAgenus’ BOT/BAL Shows 42% 2-Year Survival in MSS CRC, Moves Toward FDA Registration
Lab-on-a-Chip & Microfluidics 2025

Lab-on-a-Chip & Microfluidics 2025: Innovations in Diagnostics and 3D Bioprinting

Lab-on-a-Chip and Microfluidics World Congress 2025 Set to Explore Next-Gen Diagnostics, 3D Bioprinting, and Commercialization The 18th Annual Lab-on-a-Chip & Microfluidics World Congress 2025, now officially included in the ResearchAndMarkets.com conference offering, is poised to once again bring together innovators,…

Read MoreLab-on-a-Chip & Microfluidics 2025: Innovations in Diagnostics and 3D Bioprinting
ICON-and-Employees-Honored-for-Leadership

ICON and Employees Honored for Leadership, Innovation, and Sustainability in Clinical Research

ICON Recognized Globally for Clinical Research Leadership, Innovation, and Sustainability in 2025 ICON plc , a global leader in healthcare intelligence and clinical research, has earned multiple prestigious accolades in the first half of 2025, reinforcing its reputation as a…

Read MoreICON and Employees Honored for Leadership, Innovation, and Sustainability in Clinical Research
CorFlow’s MOCA-II Trial Approved by FDA to Advance Heart Attack Treatment

CorFlow’s MOCA-II Trial Approved by FDA to Advance Heart Attack Treatment

FDA Approves CorFlow’s MOCA-II IDE Pivotal Trial to Advance Breakthrough Heart Attack Technology CorFlow Therapeutics AG, a Swiss-based medtech innovator specializing in cardiovascular care and microvascular disease, has reached a major milestone in the development of its cutting-edge heart attack…

Read MoreCorFlow’s MOCA-II Trial Approved by FDA to Advance Heart Attack Treatment